But research on its long-term medical effects — and its impact on healthy individuals — has been hampered by the federal government’s stance on its legality, he continued. “Pharmaceutical development has been thwarted by the federal government’s seeming unwillingness to have new scientific discovery supplant long-standing ideology.”
according to the Center for Responsive Politics. Between 2004-2009, Howell was the only listed lobbyist at the firm; the RIAA was her exclusive lobbying client for most of that time. A lobbyist disclosure form describes her as working on "legislation concerning copyright laws as applied to digital music"-which she would be well-placed to do, having previously helped to write such laws.